Gastric cancer (GC) is the fifth most frequently diagnosed and the third leading cause of cancer mortality in the world (Bray et al., 2024). Due to the occult symptoms, over 60% of GC patients are diagnosed at … See more Despite dramatic progress in diagnosis and treatment, the prognosis of GC patients remains poor, primarily blamed on the frequent … See more All the data that support the findings of this study have been provided in the article/Supplementary Material, or are publicly available in the databases mentioned in the … See more WebSep 20, 2024 · CD133 has been presented as a marker of cancer stem cells in colon, pancreas, brain or lung cancer [ 35 ], yet its role in gastric CSCs is controversial. Several findings related to different aspects of gastric CSCs have been published in support of its role as a gastric CSC marker and regulator.
A Guide to Cancer Stem Cell Markers - Biocompare
WebSep 22, 2024 · Disruption of KDM4C-ALDH1A3 feed-forward loop inhibits stemness, tumorigenesis, and chemoresistance of gastric cancer stem cells. a The scores of KDM4C immunohistochemical staining in 50... WebApr 12, 2024 · The metabolic enzymes involved in one-carbon metabolism are closely associated with tumor progression and could be potential targets for cancer therapy. … closely held stp reporting
IJMS Free Full-Text SHMT2 Promotes Gastric Cancer …
WebMay 5, 2014 · In gastric cancer, cells with high expression of ALDH have stronger resistance to 5-fluorouracil (FU) and cisplatin [ 53 ]. Using CD44 + as the marker, the … WebMar 22, 2013 · Objective To investigate the correlation between CD133-positive gastric cancer and clinicopathological features and its impact on survival. Methods A search in the Medline and Chinese CNKI (up to 1 Dec 2011) was performed using the following keywords gastric cancer, CD133, AC133, prominin-1 etc. Electronic searches were supplemented … WebFeb 19, 2024 · The cell stemness was characterized by the well-defined tumorsphere formation in non-adherent and non-serum medium. Overexpression of ATF3 in SGC-7901 and MGC-803 cells decreased the size of tumorspheres in primary cultures (Fig. 4 a, b), suggesting that ATF3 inhibits self-renewal of gastric cancer stem cells in vitro. closely held corporation stock redemption